{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"LTE60","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Enrollment was stopped by the drug company during the third dose level of the Dose Escalation Phase. They discontinued clinical trials using pevonedistat. No participants were enrolled to the Dose Expansion Phase."},"pointOfContact":{"email":"jmurra33@jhmi.edu","organization":"Johns Hopkins University/SKCCC","phone":"4439273568","title":"Grants Administrative Manager"}}